Trump placed a temporary 90-day pause on the reciprocal tariff rates he announced in early April, allowing his administration months to seek out new, bilateral trade deals, but he’d also previously teased additional sectoral tariffs on pharmaceuticals and other goods to be announced in the near future.

And, when asked Monday evening, the president confirmed that it would be a matter of days before the pharmaceutical tariffs would be announced.

“I’ll announce it over the next two weeks,” he told reporters.

Trump’s comments came during a health-focused executive order signing ceremony in the Oval Office.

During that ceremony, the president took a slate of new executive actions, including signing separate orders blocking gain-of-function research in U.S. labs and directing the Food and Drug Administration to incentivize drugmakers to manufacture their products in the U.S. by streamlining federal regulations, in addition to hinting at additional healthcare actions next week.

“I think we’re going to have another conference next week, which will be very important, having to do with the world of medical, and I think we’ll be very productive,” Trump concluded.

TRUMP’S SKINNY BUDGET CALLS FOR DEFENSE SPENDING HIKE AND DOMESTIC CUTS

An analysis conducted in April by Ernst & Young found that the U.S. imported roughly $200 billion in pharmaceutical products in 2023. The analysis estimated that a 25% tariff on foreign-produced drugs would raise drug prices for Americans by more than $50 billion per year, an increase of nearly 13%.